Diagnosis | Series | N | Mean Age (range) | Males (%) | ApoE4+ (%) |
---|---|---|---|---|---|
 | ALL | 3,561 | 78 (61-105) | 1,309 (37) | 2,261 (63) |
 | JS | 864 | 78 (61-95) | 326 (38) | 549 (64) |
 | RS | 597 | 80 (61-104) | 235 (39) | 328 (55) |
AD cases | AUT | 581 | 81 (61-105) | 239 (41) | 352 (61) |
 | NCRAD | 695 | 75 (61-98) | 244 (35) | 544 (78) |
 | PS | 479 | 77 (64-90) | 161 (34) | 271 (57) |
 | NW | 345 | 80 (61-96) | 104 (30) | 217 (63) |
 | ALL | 4,683 | 77 (60-100) | 2,073 (44) | 1,122 (24) |
 | JS | 972 | 77 (60-100) | 408 (42) | 271 (28) |
 | RS | 2,406 | 78 (60-99) | 1,113 (46) | 570 (24) |
Controls | AUT | 360 | 76 (61-98) | 207 (58) | 80 (22) |
 | NCRAD | 208 | 78 (61-99) | 80 (38) | 34 (16) |
 | PS | 186 | 73 (64-91) | 43 (23) | 36 (19) |
 | NW | 551 | 75 (61-96) | 222 (40) | 132 (24) |